Literature DB >> 17207423

Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital.

Joice Mara Cruciol-Souza1, Joäo Carlos Thomson.   

Abstract

PURPOSE: The hazards of prescribing many drugs, including side-effects, drug-drug interactions (DDI) and difficulties of compliance have long been recognized as particular problems when prescribing. This study estimates the rate and factors associated with potential DDI in prescriptions from wards of a Brazilian teaching hospital.
METHODS: Data were retrieved from wards of a teaching hospital (300 beds) handwritten prescription, once a week during a period of 4 months in 2004. Potential DDI were identified using DrugReax system. Patient's age and gender, number of prescribers; number of drugs and therapeutic drug classes on prescriptions were explored as associated factors to DDI.
RESULTS: The overall frequency of potential DDI was 49.7%. The frequency of the potentially major DDI was 3.4%, with digoxin-hydrochlorothiazide as the most common interacting pair. The rate of potential DDI was significantly associated to in-patients' gender [woman, Odds ratio (OR)=1.23 (P=0.035)], age=55 years old [OR=1.5 (P=0.0008)], number of therapeutic drug class (ATC code, level 1)=4 [OR=5.5 (P=0.0000), cardiology patients [OR=7.87 (P=0.0000)] hospitalized at weekends [OR=1.24 (P=0.039)] and having digoxin prescribed [OR=16.79 (P=0.0000)]. A positive correlation was found between DDI, patient's age, number of drugs and therapeutic action ATC codes were significant, controlling for gender (Pearson's r=0.628, P=0.001).
CONCLUSIONS: Cardiology women inpatients, age more then 55 years old, 7 or more drugs prescribed (including digoxin) and hospitalized at weekends should be closely monitored for adverse outcomes from DDI. A collaborative approach toward drug selection is strongly recommended, as well as electronic prescribing and development of pharmaceutical care in Brazilian hospitals.

Entities:  

Mesh:

Year:  2006        PMID: 17207423

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  44 in total

1.  Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study.

Authors:  Paulo Roque Obreli-Neto; Alessandro Nobili; André de Oliveira Baldoni; Camilo Molino Guidoni; Divaldo Pereira de Lyra Júnior; Diogo Pilger; Juliano Duzanski; Mauro Tettamanti; Joice Mara Cruciol-Souza; Walderez Penteado Gaeti; Roberto Kenji Nakamura Cuman
Journal:  Eur J Clin Pharmacol       Date:  2012-05-30       Impact factor: 2.953

2.  Potential drug-drug interactions on in-patient medication prescriptions at Mbarara Regional Referral Hospital (MRRH) in western Uganda: prevalence, clinical importance and associated factors.

Authors:  S J Lubinga; E Uwiduhaye
Journal:  Afr Health Sci       Date:  2011-09       Impact factor: 0.927

3.  Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study.

Authors:  Cristiano Moura; Nília Prado; Francisco Acurcio
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

4.  Agreement among four drug information sources for the occurrence of warfarin drug interactions in Brazilian heart disease patients with a high prevalence of Trypanosoma cruzi infection.

Authors:  Maria A P Martins; Daniel D Ribeiro; Vandack A Nobre; Fabiana R Pereira; Cibele C César; Manoel O C Rocha; Antonio L P Ribeiro
Journal:  Eur J Clin Pharmacol       Date:  2012-09-28       Impact factor: 2.953

5.  Prevalence and nature of potential drug-drug interactions among kidney transplant patients in a German intensive care unit.

Authors:  Julia Amkreutz; Alexander Koch; Lukas Buendgens; Anja Muehlfeld; Christian Trautwein; Albrecht Eisert
Journal:  Int J Clin Pharm       Date:  2017-08-19

6.  Prevalence of potential drug-drug interactions among internal medicine ward in University of Gondar Teaching Hospital, Ethiopia.

Authors:  Akshaya Srikanth Bhagavathula; Alemayehu Berhanie; Habtamu Tigistu; Yishak Abraham; Yosheph Getachew; Tahir Mehmood Khan; Chandrashekhar Unakal
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

7.  A Prospective Analysis of Drug Interactions in Patients of Intensive Cardiac Care Unit.

Authors:  Shipra Jain; Pushpawati Jain; Kopal Sharma; Pushpendra Saraswat
Journal:  J Clin Diagn Res       Date:  2017-03-01

8.  Identification of severe potential drug-drug interactions using an Italian general-practitioner database.

Authors:  L Magro; A Conforti; F Del Zotti; R Leone; M L Iorio; I Meneghelli; D Massignani; E Visonà; U Moretti
Journal:  Eur J Clin Pharmacol       Date:  2007-11-09       Impact factor: 2.953

Review 9.  Prevalence of drug interactions in hospital healthcare.

Authors:  María Espinosa-Bosch; Bernardo Santos-Ramos; María Victoria Gil-Navarro; María Dolores Santos-Rubio; Roberto Marín-Gil; Paloma Villacorta-Linaza
Journal:  Int J Clin Pharm       Date:  2012-09-11

10.  Risk of digoxin intoxication caused by clarithromycin-digoxin interactions in heart failure patients: a population-based study.

Authors:  Agnes L F Chan; Meng-Ting Wang; Chen-Yi Su; Fu-Hsiung Tsai
Journal:  Eur J Clin Pharmacol       Date:  2009-12       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.